Aligos Therapeutics, Inc. (ALGS) Halted Development of its Lead Drug Candidate Robbins LLP is investigating Aligos Therapeutics, Inc. (NASDAQ: ALGS) to determine whether certain Aligos officers and directors violated securities laws

NRx Pharmaceutical, Inc. (NRXP) Misled Investors Regarding the EUA Status of its Drug Candidate    A shareholder filed a class action on behalf of all persons who purchased or otherwise

DocuSign, Inc. (DOCU) Made Material Misstatements Regarding its Business Prospects A class action was filed on behalf of all persons and entities that purchased DocuSign, Inc. (NASDAQ: DOCU) securities between

Arrival SA (ARVL, ARVLW) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired common shares of

First Solar, Inc. (FSLR) Made Misrepresentations Regarding its Series 6 Solar Module A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired

Bright Health Group, Inc. (BHG) Issued a Misleading Registration Statement in Connection with its IPO   A shareholder filed a class action on behalf of all persons and entities that

Desktop Metal, Inc. (DM) Failed to Disclose Deficiencies in EnvisionTEC’s Manufacturing and Product Compliance Practices and Procedures A class action was filed on behalf of all persons and entities that

Faraday Future Intelligent Electric Inc. (FFIE, FFIEW) Misled Shareholders Regarding its Ability to Deliver Vehicles    A shareholder filed a class action on behalf of persons and entities that purchased

Instadose Pharma Corp. (INSD) Misled Investors Causing a Halt in Trading     A shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Instadose